Evidence map›Paper›PMID 37569484›Full record

ReviewInternational journal of molecular sciences2023

Angiotensin Regulation of Vascular Homeostasis: Exploring the Role of ROS and RAS Blockers.

Nikolaos Koumallos, Evangelia Sigala, Theodoros Milas, Nikolaos G Baikoussis, Dimitrios Aragiannis, Skevos Sideris, Konstantinos Tsioufis

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. PMToxics · 2024
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nikolaos KoumallosCardiothoracic Department, Hippokration Hospital of Athens, 11527 Athens, Greece.ORCID 0000-0001-6489-5403
Evangelia SigalaCardiothoracic Department, Hippokration Hospital of Athens, 11527 Athens, Greece.ORCID 0000-0002-0871-6164
Theodoros MilasCardiothoracic Department, Hippokration Hospital of Athens, 11527 Athens, Greece.
Nikolaos G BaikoussisCardiothoracic Department, Hippokration Hospital of Athens, 11527 Athens, Greece.ORCID 0000-0001-5645-662X
Dimitrios AragiannisCardiology Department, Hippokration Hospital of Athens, 11527 Athens, Greece.
Skevos SiderisCardiology Department, Hippokration Hospital of Athens, 11527 Athens, Greece.
Konstantinos TsioufisCardiology Department, Hippokration Hospital of Athens, 11527 Athens, Greece.
Hippocration General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive research has been conducted to elucidate and substantiate the crucial role of the Renin-Angiotensin System (RAS) in the pathogenesis of hypertension, cardiovascular disorders, and renal diseases. Furthermore, the role of oxidative stress in maintaining vascular balance has been well established. It has been observed that many of the cellular effects induced by Angiotensin II (Ang II) are facilitated by reactive oxygen species (ROS) produced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. In this paper, we present a comprehensive overview of the role of ROS in the physiology of human blood vessels, specifically focusing on its interaction with RAS. Moreover, we delve into the mechanisms by which clinical interventions targeting RAS influence redox signaling in the vascular wall.

Indexed as

HypertensionRenin-Angiotensin SystemAngiotensin IIHomeostasisHumansNADPH OxidasesReactive Oxygen SpeciesAngiotensin IINADPH OxidasesReactive Oxygen SpeciesACE inhibitorsARBsoxidative stressRASredox signaling

Identifiers

PMID37569484
PMCPMC10418800
OpenAlexW4385342633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.